ENHANCED MR-IMAGING OF THE LIVER AFTER ETHANOL TREATMENT OF HEPATOCELLULAR-CARCINOMA - EVALUATION OF AREAS OF HYPERPERFUSION ADJACENT TO THE TUMOR

被引:26
作者
ITO, K
HONJO, K
FUJITA, T
AWAYA, H
MATSUMOTO, T
MATSUNAGA, N
机构
[1] Department of Radiology, Yamaguchi Univ. School of Medicine, Ube, Yamaguchi 755
关键词
D O I
10.2214/ajr.164.6.7754884
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. In the arterial phase of dynamic contrast-enhanced MR images, we observed areas of increased contrast enhancement adjacent to hepatocellular carcinomas treated by percutaneous ethanol injection. The purpose of this study was to assess the frequency, appearance, and location of this hyperperfusion abnormality. it is important not to mistake this finding for other pathologic conditions. SUBJECTS AND METHODS. Multisection dynamic MR images obtained in 33 consecutive patients with hepatocellular carcinoma treated with percutaneous ethanol injection were reviewed. Hepatic parenchymal hyperperfusion abnormalities were diagnosed when areas of early enhancement were seen in the hepatic parenchyma adjacent to the treated tumor. The location, appearance, and frequency of the findings were recorded. RESULTS. Hepatic parenchymal hyperperfusion abnormalities were observed in 15 (45%) of the 33 patients on arterial-dominant-phase images. Of these 15 patients, 10 (67%) had MR imaging within 1 month after percutaneous ethanol injection. Hyperperfusion abnormalities were located in liver parenchyma adjacent to the lesion with wedge shaped appearances. In two patients, early opacification of the peripheral portal branch was seen within the area of hyperperfusion abnormalities. CONCLUSION. Hepatic hyperperfusion abnormalities are commonly seen adjacent to a treated hepatocellular carcinoma on contrast-enhanced MR images. Awareness of this hyperperfusion abnormality, which is caused by increased blood flow after percutaneous ethanol injection, is important because such a finding may be misinterpreted as another pathologic condition such as tumor progression or tumor thrombosis of the portal vein branches.
引用
收藏
页码:1413 / 1417
页数:5
相关论文
共 50 条
  • [31] Hepatocellular carcinoma: Detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver
    Pauleit, D
    Textor, J
    Bachmann, R
    Conrad, R
    Flacke, S
    Layer, G
    Kreft, B
    Schild, H
    RADIOLOGY, 2002, 222 (01) : 73 - 80
  • [32] MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine
    Marco Dioguardi Burgio
    Dario Picone
    Giuseppe Cabibbo
    Massimo Midiri
    Roberto Lagalla
    Giuseppe Brancatelli
    Abdominal Radiology, 2016, 41 : 1546 - 1554
  • [33] MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine
    Burgio, Marco Dioguardi
    Picone, Dario
    Cabibbo, Giuseppe
    Midiri, Massimo
    Lagalla, Roberto
    Brancatelli, Giuseppe
    ABDOMINAL RADIOLOGY, 2016, 41 (08) : 1546 - 1554
  • [34] Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: Correlation with histologic tumor grade and tumor vascularity
    Kato, H
    Kanematsu, M
    Kondo, H
    Goshima, S
    Matsuo, M
    Hoshi, H
    Moriyama, N
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2004, 19 (01) : 76 - 81
  • [35] Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: Correlation with histologic tumor grade and tumor vascularity
    Kondo, H
    Kanematsu, M
    Matsuo, M
    Hoshi, H
    RADIOLOGY, 2002, 225 : 581 - 581
  • [36] LIVER ATROPHY AFTER TRANSCATHETER ARTERIAL EMBOLIZATION AND PERCUTANEOUS ETHANOL INJECTION THERAPY FOR A MINUTE HEPATOCELLULAR-CARCINOMA
    MOTOO, Y
    OKAI, T
    MATSUI, O
    OHTA, H
    SAWABU, N
    GASTROINTESTINAL RADIOLOGY, 1991, 16 (02): : 164 - 166
  • [37] HEPATOCELLULAR-CARCINOMA NOT DETECTED WITH PLAIN US - TREATMENT WITH PERCUTANEOUS ETHANOL INJECTION UNDER GUIDANCE WITH ENHANCED US
    IMARI, Y
    SAKAMOTO, S
    SHIOMICHI, S
    ISOBE, H
    IKEDA, M
    SATOH, M
    NAWATA, H
    RADIOLOGY, 1992, 185 (02) : 497 - 500
  • [38] EVALUATION OF RADIATION-INDUCED LIVER-INJURY WITH MR-IMAGING - COMPARISON OF HEPATOCELLULAR AND RETICULOENDOTHELIAL CONTRAST AGENTS
    CLEMENT, O
    MUHLER, A
    VEXLER, VS
    ROSENAU, W
    BERTHEZENE, Y
    KUWATSURU, R
    BRASCH, RC
    RADIOLOGY, 1992, 185 (01) : 163 - 168
  • [39] Detection of hepatocellular carcinoma in the liver: Should gadolinium-enhanced or SPIO-enhanced MR imaging be preferred?
    Pauleit, DO
    Bachmann, R
    Conrad, R
    Kreft, BP
    Textor, J
    Schild, HH
    RADIOLOGY, 1999, 213P : 170 - 170
  • [40] LIVER-ABSCESS AFTER PERCUTANEOUS ETHANOL INJECTION (PEI) THERAPY FOR HEPATOCELLULAR-CARCINOMA - A CASE-REPORT
    OKADA, S
    AOKI, K
    OKAZAKI, N
    NOSE, H
    YOSHIMORI, M
    SHIMADA, K
    YAMAMOTO, J
    TAKAYAMA, T
    KOSUGE, T
    YAMASAKI, S
    TAKAYASU, K
    MORIYAMA, N
    HEPATO-GASTROENTEROLOGY, 1993, 40 (05) : 496 - 498